{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T06:11:02Z","timestamp":1744179062136},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"4","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J. Huazhong Univ. Sci. Technol. [Med. Sci.]"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1007\/s11596-017-1781-1","type":"journal-article","created":{"date-parts":[[2018,1,8]],"date-time":"2018-01-08T22:09:40Z","timestamp":1515449380000},"page":"621-627","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Time-series analysis in imatinib-resistant chronic myeloid leukemia K562-cells under different drug treatments"],"prefix":"10.1007","volume":"37","author":[{"given":"Yan-hong","family":"Zhao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xue-fang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan-qiu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Bai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan","family":"Qin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ying","family":"Dong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,8,8]]},"reference":[{"key":"1781_CR1","doi-asserted-by":"crossref","unstructured":"Adamia S, Pilarski PM, Bar-Natan M, et al. Alternative splicing in chronic myeloid leukemia (CML): a novel therapeutic target? Current Cancer Drug Targets, 2013,13(7):735\u2013748","DOI":"10.2174\/15680096113139990083"},{"issue":"1","key":"1781_CR2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/bjh.13108","volume":"168","author":"JE Cortes","year":"2015","unstructured":"Cortes JE, Kim DW, Kantarjian HM, et al. Bosutinib versus imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: results from the BELA trial. Br J Haematol, 2015,168(1):69\u201381","journal-title":"Br J Haematol"},{"issue":"2","key":"1781_CR3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1007\/s00277-015-2314-2","volume":"94","author":"M H\u00f6glund","year":"2015","unstructured":"H\u00f6glund M, Sandin F, Simonsson B. Epidemiology of chronic myeloid leukaemia: an update. Ann Hematol, 2015,94(2):241\u2013247.","journal-title":"Ann Hematol"},{"issue":"10","key":"1781_CR4","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1016\/j.leukres.2010.04.016","volume":"34","author":"X An","year":"2010","unstructured":"An X, Tiwari AK, Sun Y, et al. BCR-ABL tyrosine kinase inhibitors in the treatment of Philadelphia chromosome positive chronic myeloid leukemia: A review. Leuk Res, 2010,34(10):1255\u20131268","journal-title":"Leuk Res"},{"issue":"2","key":"1781_CR5","doi-asserted-by":"crossref","first-page":"232","DOI":"10.3324\/haematol.2009.011452","volume":"95","author":"NP Shah","year":"2010","unstructured":"Shah NP, Kim DW, Kantarjian H, et al. Potent, transient inhibition of BCR-ABL with dasatinib 100 mg daily achieves rapid and durable cytogenetic responses and high transformation-free survival rates in chronic phase chronic myeloid leukemia patients with resistance, suboptimal response or intolerance to imatinib. Haematologica, 2010,95(2):232\u2013240","journal-title":"Haematologica"},{"issue":"5","key":"1781_CR6","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1182\/blood-2011-08-376087","volume":"119","author":"HM Kantarjian","year":"2012","unstructured":"Kantarjian HM, Shah NP, Cortes JE, et al. Dasatinib or imatinib in newly diagnosed chronic-phase chronic myeloid leukemia: 2-year follow-up from a randomized phase 3 trial (DASISION). Blood, 2012,119(5):1123\u20131129","journal-title":"Blood"},{"issue":"4","key":"1781_CR7","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1182\/blood-2007-04-083196","volume":"111","author":"P Coutre le","year":"2008","unstructured":"le Coutre P, Ottmann OG, Giles F, et al. Nilotinib (formerly AMN107), a highly selective BCR-ABL tyrosine kinase inhibitor, is active in patients with imatinib-resistant or -intolerant accelerated-phase chronic myelogenous leukemia. Blood, 2008,111(4):1834\u20131839","journal-title":"Blood"},{"issue":"7","key":"1781_CR8","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1111\/j.1349-7006.2010.01584.x","volume":"101","author":"K Naka","year":"2010","unstructured":"Naka K, Hoshii T, Hirao A. Novel therapeutic approach to eradicate tyrosine kinase inhibitor resistant chronic myeloid leukemia stem cells. Cancer Sci, 2010,101(7):1577\u20131581","journal-title":"Cancer Sci"},{"issue":"8","key":"1781_CR9","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1177\/1535370213492689","volume":"238","author":"Y Xia","year":"2013","unstructured":"Xia Y, Fang H, Zhang J, et al. Endoplasmic reticulum stress-mediated apoptosis in imatinib-resistant leukemic K562-r cells triggered by AMN107 combined with arsenic trioxide. Exp Biol Med (Haywood), 2013,238(8):932\u2013942","journal-title":"Exp Biol Med (Haywood)"},{"issue":"1","key":"1781_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12935-015-0156-6","volume":"15","author":"W Wang","year":"2015","unstructured":"Wang W, Lv FF, Du Y, et al. The effect of nilotinib plus arsenic trioxide on the proliferation and differentiation of primary leukemic cells from patients with chronic myoloid leukemia in blast crisis. Cancer Cell International, 2015,15(1):1\u20138","journal-title":"Cancer Cell International"},{"issue":"5","key":"1781_CR11","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1142\/S0219720008003746","volume":"6","author":"A Fujita","year":"2008","unstructured":"Fujita A, Sato JR, Garay-Malpartida HM, et al. Modeling nonlinear gene regulatory networks from time series gene expression data. J Bioinform Comput Biol, 2008,6(5):961\u2013979","journal-title":"J Bioinform Comput Biol"},{"issue":"3","key":"1781_CR12","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1614\/WT-06-161.1","volume":"21","author":"SZ Knezevic","year":"2007","unstructured":"Knezevic SZ, Streibig JC, Ritz C. Utilizing R software package for dose-response studies: The concept and data analysis. Weed Technol, 2007,21(3):840\u2013848","journal-title":"Weed Technol"},{"key":"1781_CR13","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1471-2164-12-2","volume":"12","author":"SA Ghandhi","year":"2011","unstructured":"Ghandhi SA, Sinha A, Markatou M, et al. Time-series clustering of gene expression in irradiated and bystander fibroblasts: an application of FBPA clustering. BMC Genomics, 2011,12:2","journal-title":"BMC Genomics"},{"issue":"5","key":"1781_CR14","doi-asserted-by":"crossref","first-page":"P3","DOI":"10.1186\/gb-2003-4-5-p3","volume":"4","author":"G Dennis","year":"2003","unstructured":"Dennis G, Sherman BT, Hosack DA, et al. DAVID: Database for Annotation, Visualization, and Integrated Discovery. Genome Biol, 2003,4(5):P3","journal-title":"Genome Biol"},{"issue":"1","key":"1781_CR15","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","volume":"57","author":"Y Benjamini","year":"1995","unstructured":"Benjamini Y, Hochberg Y. Controlling the false discovery rate -a practical and powerful approach to multiple testing. J Roy Stat Soc B Met, 1995,57(1):289\u2013300","journal-title":"J Roy Stat Soc B Met"},{"key":"1781_CR16","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1471-2105-7-191","volume":"7","author":"J Ernst","year":"2006","unstructured":"Ernst J, Bar-Joseph Z. STEM: a tool for the analysis of short time series gene expression data. BMC Bioinformatics, 2006,7:191","journal-title":"BMC Bioinformatics"},{"key":"1781_CR17","doi-asserted-by":"crossref","first-page":"D258","DOI":"10.1093\/nar\/gkh066","volume":"32","author":"MA Harris","year":"2004","unstructured":"Harris MA, Clark J, Ireland A, et al. The Gene Ontology (GO) database and informatics resource. Nucleic Acids Res, 2004,32(Database issue):D258\u2013261","journal-title":"Nucleic Acids Res"},{"issue":"5","key":"1781_CR18","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1038\/leu.2008.392","volume":"23","author":"I Bruns","year":"2009","unstructured":"Bruns I, Czibere A, Fischer JC, et al. The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence. Leukemia, 2009,23(5):892\u2013899","journal-title":"Leukemia"},{"issue":"1","key":"1781_CR19","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.ijrobp.2014.04.055","volume":"90","author":"B Wang","year":"2014","unstructured":"Wang B, Li D, Kovalchuk A, et al. Ionizing radiation-inducible miR-27b suppresses leukemia proliferation via targeting cyclin A2. Int J Radiat Oncol Biol Phys, 2014,90(1):53\u201362","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"9","key":"1781_CR20","doi-asserted-by":"crossref","first-page":"3378","DOI":"10.1073\/pnas.0813142106","volume":"106","author":"QY Zhang","year":"2009","unstructured":"Zhang QY, Mao JH, Liu P, et al. A systems biology understanding of the synergistic effects of arsenic sulfide and Imatinib in BCR\/ABL-associated leukemia. Proc Natl Acad Sci U S A, 2009,106(9):3378\u20133383","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"1781_CR21","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/83751","volume":"27","author":"RJ Cho","year":"2001","unstructured":"Cho RJ, Huang M, Campbell MJ, et al. Transcriptional regulation and function during the human cell cycle. Nat Genet, 2001,27(1):48\u201354","journal-title":"Nat Genet"},{"issue":"2","key":"1781_CR22","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1083\/jcb.133.2.391","volume":"133","author":"X Zhu","year":"1996","unstructured":"Zhu X, Ohtsubo M, B\u00f6hmer RM, et al. Adhesion-dependent cell cycle progression linked to the expression of cyclin D1, activation of cyclin E-cdk2, and phosphorylation of the retinoblastoma protein. J Cell Biol, 1996,133(2):391\u2013403","journal-title":"J Cell Biol"},{"issue":"7","key":"1781_CR23","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1242\/dev.078238","volume":"139","author":"EL Cadwalader","year":"2012","unstructured":"Cadwalader EL, Condic ML, Yost HJ. 2-O-sulfotransferase regulates Wnt signaling, cell adhesion and cell cycle during zebrafish epiboly. Development, 2012,139(7):1296\u20131305","journal-title":"Development"},{"issue":"4","key":"1781_CR24","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1002\/ijc.28427","volume":"134","author":"RM Eit El","year":"2014","unstructured":"El Eit RM, Iskandarani AN, Saliba JL, et al. Effective targeting of chronic myeloid leukemia initiating activity with the combination of arsenic trioxide and interferon alpha. Int J Cancer, 2014,134(4):988\u2013996","journal-title":"Int J Cancer"},{"issue":"7281","key":"1781_CR25","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/nature08734","volume":"463","author":"K Naka","year":"2010","unstructured":"Naka K, Hoshii T, Muraguchi T, et al. TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia. Nature, 2010,463(7281):676\u2013680","journal-title":"Nature"},{"issue":"9","key":"1781_CR26","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/nrm2957","volume":"11","author":"JT Parsons","year":"2010","unstructured":"Parsons JT, Horwitz AR, Schwartz MA. Cell adhesion: integrating cytoskeletal dynamics and cellular tension. Nat Rev Molecul Cell Biol, 2010,11(9):633\u2013643","journal-title":"Nat Rev Molecul Cell Biol"},{"issue":"5","key":"1781_CR27","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.yexcr.2012.01.013","volume":"318","author":"SM Cheong","year":"2012","unstructured":"Cheong SM, Choi H, Hong BS, et al. Dab2 is pivotal for endothelial cell migration by mediating VEGF expression in cancer cells. Exp Cell Res, 2012,318(5):550\u2013557","journal-title":"Exp Cell Res"},{"issue":"9","key":"1781_CR28","doi-asserted-by":"crossref","first-page":"4793","DOI":"10.7314\/APJCP.2012.13.9.4793","volume":"13","author":"XD Huang","year":"2012","unstructured":"Huang XD, Wang ZF, Dai LM, et al. Microarray analysis of the hypoxia-induced gene expression profile in malignant C6 glioma cells. Asian Pac J Cancer Prev, 2012,13(9):4793\u20134799","journal-title":"Asian Pac J Cancer Prev"},{"issue":"13","key":"1781_CR29","doi-asserted-by":"crossref","first-page":"4941","DOI":"10.1158\/1078-0432.CCR-04-2601","volume":"11","author":"M Golemovic","year":"2005","unstructured":"Golemovic M, Verstovsek S, Giles F, et al. AMN107, a novel aminopyrimidine inhibitor of Bcr-Abl, has in vitro activity against imatinib-resistant chronic myeloid leukemia. Clin Cancer Res, 2005,11(13):4941\u20134947","journal-title":"Clin Cancer Res"},{"issue":"3","key":"1781_CR30","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/path.4246","volume":"231","author":"S Suresh","year":"2013","unstructured":"Suresh S, Mccallum L, Crawford LJ, et al. The matricellular protein CCN3 regulates NOTCH1 signalling in chronic myeloid leukaemia. J Pathol, 2013,231(3):378\u2013387","journal-title":"J Pathol"},{"issue":"4","key":"1781_CR31","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1038\/leu.2012.313","volume":"27","author":"M Talpaz","year":"2013","unstructured":"Talpaz M, Hehlmann R, Quint\u00e1s-Cardama A, et al. Re-emergence of interferon-a in the treatment of chronic myeloid leukemia. Leukemia, 2013,27(4):803\u2013812","journal-title":"Leukemia"},{"issue":"4","key":"1781_CR32","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/vim.2011.0099","volume":"25","author":"W Hu","year":"2012","unstructured":"Hu W, Yen YT, Singh S, et al. SARS-CoV regulates immune function-related gene expression in human monocytic cells. Viral Immunol, 2012,25(4):277\u2013288","journal-title":"Viral Immunol"},{"issue":"5","key":"1781_CR33","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s11596-015-1491-5","volume":"35","author":"Y Bai","year":"2015","unstructured":"Bai Y, Zheng J, Wang N, et al. Effects of dendritic cell-activated and cytokine-induced killer cell therapy on 22 children with acute myeloid leukemia after chemotherapy. J Huazhong Univ Sci Technol Med Sci, 2015,35(5):689\u2013693","journal-title":"J Huazhong Univ Sci Technol Med Sci"},{"issue":"2","key":"1781_CR34","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1111\/ejh.12306","volume":"93","author":"S Brown","year":"2014","unstructured":"Brown S, Hutchinson CV, Aspinall-O\u2019Dea M, et al. Monocyte-derived dendritic cells from chronic myeloid leukaemia have abnormal maturation and cytoskeletal function that is associated with defective localisation and signalling by normal ABL1 protein. Eur J Haematol, 2014,93(2):96\u2013102","journal-title":"Eur J Haematol"}],"container-title":["Journal of Huazhong University of Science and Technology [Medical Sciences]"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-017-1781-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11596-017-1781-1\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11596-017-1781-1.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,30]],"date-time":"2024-06-30T10:36:28Z","timestamp":1719743788000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11596-017-1781-1"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,8]]},"references-count":34,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["1781"],"URL":"https:\/\/doi.org\/10.1007\/s11596-017-1781-1","relation":{},"ISSN":["1672-0733"],"issn-type":[{"value":"1672-0733","type":"print"}],"subject":[],"published":{"date-parts":[[2017,8]]}}}